Los puntos clave no están disponibles para este artículo en este momento.
particles/mL. As a proof of concept, this SERS platform was successfully applied to distinguish cervical cancer patients from healthy individuals by analyzing Exos in clinical serum samples, enabling early and noninvasive cancer diagnosis.
Diao et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: